Cellular Therapy for Sepsis

Management of Sepsis: The Surviving Sepsis Guidelines for Early Therapy

Hospital Physician June 2007 21 Sepsis is a common condition that is associated with poor patient outcomes and high financial costs. An estimated 750,000 cases of sepsis occur each year. Because sepsis is more common in elderly patients, its incidence is expected to rise as the US population ages.1 Despite recent advances in management and therapy, the mortality rate from severe sepsis remains ...

Assessing Cellular Responses in Sepsis☆

Sepsis – defined as a dysregulated immunological response to infection associated with some degree of associated organ dysfunction (Vincent et al., 2013) – is a common problem and still complicated by unacceptably high mortality rates. Infection is treated with antibiotics, and source control when needed, but there is no effective, specific treatment for sepsis. The only drug that has ever been...

Sepsis: Antimicrobial Therapy

Medication Therapy for Early-Onset Neonatal Sepsis.

S sepsis is a common cause of morbidity and mortality in neonates. In a population-based surveillance study1 from 2005 to 2008, researchers estimated that 3300 cases of early-onset sepsis (EOS) occur in the United States each year, with 390 of these cases resulting in death. The risk is highest in preterm neonates, which account for 1570 of the 3300 cases and 360 deaths.1 Despite its prevalence...

Cellular Therapy for Heart Failure

The pathogenesis of cardiomyopathy and heart failure (HF) is underpinned by complex changes at subcellular, cellular and extracellular levels in the ventricular myocardium. For all of the gains that conventional treatments for HF have brought to mortality and morbidity, they do not adequately address the loss of cardiomyocyte numbers in the remodeling ventricle. Originally conceived to address ...